tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VAXX Stock Latest News

Vaxxinity’s Parkinson’s candidate UB-312 demonstrates efficacy in publication
The FlyVaxxinity’s Parkinson’s candidate UB-312 demonstrates efficacy in publication
3M ago
VAXX
Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
PremiumPress Releases
Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
3M ago
VAXX
Vaxxinity Issues Shareholder Letter
PremiumPress Releases
Vaxxinity Issues Shareholder Letter
5M ago
VAXX
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
PremiumPress Releases
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
5M ago
VAXX
Vaxxinity to voluntarily delist, deregister its Class A common stock
PremiumThe Fly
Vaxxinity to voluntarily delist, deregister its Class A common stock
5M ago
VAXX
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
PremiumPress ReleasesVaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
6M ago
VAXX
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
Premium
Press Releases
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
6M ago
VAXX
VAXX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VAXX Earnings this Week: How Will it Perform?
6M ago
VAXX
Vaxxinity Inc Motivates Team with Option Repricing Initiative
PremiumCompany Announcements
Vaxxinity Inc Motivates Team with Option Repricing Initiative
6M ago
8K
VAXX
Vaxxinity announces ‘positive’ target engagement data from Phase 1 trial
PremiumThe Fly
Vaxxinity announces ‘positive’ target engagement data from Phase 1 trial
7M ago
VAXX
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
PremiumPress Releases
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
7M ago
VAXX
Vaxxinity Faces Nasdaq Delisting Over Share Price
PremiumCompany Announcements
Vaxxinity Faces Nasdaq Delisting Over Share Price
7M ago
8K
VAXX
Vaxxinity announces publication of data on VXX-401
PremiumThe FlyVaxxinity announces publication of data on VXX-401
7M ago
VAXX
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
Premium
Press Releases
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
7M ago
VAXX
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
Premium
Press Releases
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
7M ago
VAXX
Vaxxinity announces research collaboration with CTRND
PremiumThe Fly
Vaxxinity announces research collaboration with CTRND
8M ago
VAXX
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
PremiumPress Releases
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
8M ago
VAXX
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
PremiumPress Releases
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
8M ago
VAXX
Vaxxinity announces collaboration on space medicine research with UCF
PremiumThe Fly
Vaxxinity announces collaboration on space medicine research with UCF
8M ago
VAXX
Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
PremiumPress ReleasesVaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
9M ago
VAXX
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
Premium
Press Releases
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
10M ago
VAXX
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Premium
Press Releases
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
11M ago
VAXX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >